Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.
about
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusPatient-adjusted versus health professional-adjusted insulin dosing for type 2 diabetes mellitusDapagliflozin for type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusEffect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trialsSGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?Diabetes DyslipidemiaThe Impact of Automated Brief Messages Promoting Lifestyle Changes Delivered Via Mobile Devices to People with Type 2 Diabetes: A Systematic Literature Review and Meta-Analysis of Controlled TrialsGenetics of cardiovascular and renal complications in diabetesEarly Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular TrialsPolypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 DiabetesSecondary stroke prevention: challenges and solutionsDiabetic Cardiomyopathy; Summary of 41 YearsLow HbA1c and Increased Mortality Risk-is Frailty a Confounding Factor?Cardiovascular effects of basal insulinsModulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospectsBenefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesGlycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysisCardiovascular importance of hyperglycemia and hypoglycemiaEfficacy of intensive control of glucose in stroke prevention: a meta-analysis of data from 59,197 participants in 9 randomized controlled trialsPrognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysisGlycemic control and cardiovascular disease: what's a doctor to do?Insulin use early in the course of type 2 diabetes mellitus: the ORIGIN trialUpdate on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes MellitusPrevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based StudiesEffect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trialsNew genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes riskDietary fiber intake is associated with HbA1c level among prevalent patients with type 2 diabetes in Pudong New Area of Shanghai, ChinaRecent HbA1c values and mortality risk in type 2 diabetes. population-based case-control studyAll-cause mortality in patients with type 2 diabetes in association with achieved hemoglobin A(1c), systolic blood pressure, and low-density lipoprotein cholesterol levelsCardiovascular toxicity of multi-tyrosine kinase inhibitors in advanced solid tumors: a population-based observational studyHbA1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitusDiabetes and Clinical and Subclinical CVD.Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease.Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties.Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.Cardiovascular risk factor management of myocardial infarction patients with and without diabetes in the Netherlands between 2002 and 2006: a cross-sectional analysis of baseline data
P2860
Q24186667-56CF5DB9-A486-4E22-9529-B131089DBD6AQ24202505-9F50E60E-943A-455B-BF1D-8179C391BE83Q24202547-1985A55B-857B-424C-B126-6B986E15C31BQ24234557-73C9730F-2FC3-44AB-A111-549D4797F399Q24236456-8B0EA8CA-8B83-4A52-A877-167A8F42F7F3Q24241529-4771A954-DE34-43D7-B356-EFD9677445C5Q24628988-75F49438-DF90-4EDE-888A-BAFD2364256DQ26750510-09649F7E-E351-4ADC-A682-B4EC98962950Q26750905-1B0C80BF-FAD6-4708-AD75-35805A15E7C5Q26752258-30E795A0-5F37-48A0-BE36-145806C4B5E5Q26752749-804B304F-F069-44CE-A0CE-01A4257A2105Q26767164-9E13E331-3523-43E6-BB87-627A2DD98200Q26767283-2128BDA9-3C76-4FAF-92E0-7676D800D29DQ26795568-7CA10B28-0EBF-4E6A-995D-A745C5920F2CQ26799318-CDCE2168-FBE8-4D33-864D-7CEE8A6E0486Q26799903-2F78F2E7-F0F4-4034-A500-89B2370D2A4FQ26800249-06D0D4B5-8D7B-4F25-8C09-0FBA66B83B59Q26829098-77639761-C61F-48A7-8184-95E51B5A065BQ26853571-1AB45408-60D7-480D-A6F6-2441B321E01EQ26860467-CE86C980-E8F2-4505-B238-B64928EF6653Q26999390-5C5E0BD4-DBC8-4487-97E7-99A8867981BFQ27008807-EB2D2620-69FA-4CBA-89C2-999E85527315Q27021243-D2DEE3AB-95AB-4AF7-88E5-0E6EAB8870F5Q27024469-74134444-478F-468A-9EFA-21FD279A4FC5Q27024597-12A77F85-6C82-4752-BEF0-4257B985B1EDQ27687851-E1CA0DF5-0524-452F-9CAE-321B632E8CE2Q28072980-4CBEC7DF-D7D4-41E0-A963-E523D76B41CEQ28084768-E2D1CDA8-F999-4860-8076-2CEE8543E803Q28256514-ED02AFEC-BD4F-4511-B17B-DD13278310CDQ28270700-0F537CC9-5ABB-4A55-9A50-69F3EB1BA695Q28484431-9E40F1CA-6277-4BC2-B33C-826F888B8F54Q28534542-FAC21D9B-AF6C-4CB9-ABDA-6F0A60326BFAQ28544402-68A85337-CC56-401D-AD79-AEA14B98D1BBQ28545130-E2C2EEA0-2E50-4DD9-B7C8-2C3A339C0798Q28728521-F130856C-0534-40ED-BD86-BB6FE5931CC2Q30244573-C3AB9E86-C523-4686-8A51-AF8EDDEE5851Q30249156-68A483A5-15A6-4EB8-A796-A2FD9AFAEFC1Q30399061-377C0A4F-562A-411D-A8ED-0C5FD80D9891Q30426632-02381C80-DCEE-4F27-BF11-58BDC0DFE6ECQ30530802-66CB9784-1038-4FA0-B13E-35A5B2D1C4B8
P2860
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Effect of intensive control of ...... randomised controlled trials.
@ast
Effect of intensive control of ...... randomised controlled trials.
@en
Effect of intensive control of ...... randomised controlled trials.
@nl
type
label
Effect of intensive control of ...... randomised controlled trials.
@ast
Effect of intensive control of ...... randomised controlled trials.
@en
Effect of intensive control of ...... randomised controlled trials.
@nl
prefLabel
Effect of intensive control of ...... randomised controlled trials.
@ast
Effect of intensive control of ...... randomised controlled trials.
@en
Effect of intensive control of ...... randomised controlled trials.
@nl
P2093
P921
P1433
P1476
Effect of intensive control of ...... randomised controlled trials.
@en
P2093
Kausik K Ray
Rupa Sivakumaran
Sarah Nethercott
Sebhat Erqou
Shanelle Wijesuriya
Sreenivasa Rao Kondapally Seshasai
P304
P356
10.1016/S0140-6736(09)60697-8
P407
P577
2009-05-01T00:00:00Z